Emmis Acquisition (EMIS) vs Whitehawk Therapeutics (WHWK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 18, 2026.
Summary
Whitehawk Therapeutics (WHWK) has outperformed Emmis Acquisition (EMIS) over the past year, gaining 30.8% versus a gain of 3.3%. Whitehawk Therapeutics is the larger company by market cap ($164.8 million vs $162.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMIS | WHWK |
|---|---|---|
| Share price | $10.28 | $2.89 |
| Market cap | $162.18M | $164.76M |
| 1-day change | +0.10% | -4.93% |
| YTD return | +3.32% | +19.42% |
| 1-year return | +3.32% | +30.77% |
| 5-year return | — | -89.33% |
| EPS (TTM) | — | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $7.14M |
| Revenue growth (YoY) | — | -72.50% |
| Net income (latest FY) | — | $-20.60M |
| Gross margin | — | 89.36% |
| Operating margin | — | -1601.12% |
| Net margin | — | -288.26% |
| 52-week high | $10.28 | $5.50 |
| 52-week low | $9.90 | $1.97 |
| Distance from 52-week high | 0.00% | -47.41% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +166.78% |
| Average volume | 14.46K | 363.96K |
| Shares outstanding | 11.94M | 57.01M |
| Employees | — | 32 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- WHWK has outperformed EMIS by 27.5 percentage points over the past year.
About Emmis Acquisition
EMIS stock →Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Health Care · Biotechnology: Pharmaceutical Preparations
About Whitehawk Therapeutics
WHWK stock →Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
EMIS vs WHWK FAQ
Which is bigger, Emmis Acquisition or Whitehawk Therapeutics?
Whitehawk Therapeutics (WHWK) is larger, with a market capitalization of $164.76M compared with $162.18M for Emmis Acquisition (EMIS).
Which stock has performed better over the past year, EMIS or WHWK?
WHWK returned +30.77% over the past 12 months, compared with +3.32% for EMIS (price return, excluding dividends). Past performance does not predict future results.
Are Emmis Acquisition and Whitehawk Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.